Navigation Links
Will the Nagoya Protocol impact your synthetic biology research?
Date:11/4/2013

WASHINGTON The United Nations (UN) is working to ensure that the benefits of genetic resources are shared in a fair and equitable way via the Nagoya Protocol to the Convention on Biological Diversity, though questions remain about how this treaty will impact research in synthetic biology.

A new report from the Synthetic Biology Project at the Woodrow Wilson International Center for Scholars looks at how the protocol may affect U.S. researchers working in the field of synthetic biology.

The Nagoya Protocol was adopted in 2010 to provide a transparent legal framework for sharing genetic resources. "Its objective is the fair and equitable sharing of benefits arising from the utilization of genetic resources, thereby contributing to the conservation and sustainable use of biodiversity," according to the UN.

But the report finds significant uncertainty surrounding what sorts of genetic material is covered and when the protocol would go into effect. For example:

Would synthetic DNA or "biobricks" be covered? Would genetic samples collected prior to the ratification of the treaty be covered? Would digital DNA sequences shared over the web be covered?

Despite this uncertainty and despite the fact the United States is not a signatory to the Nagoya Protocol or the Convention on Biological Diversity, the report suggests that U.S. researchers engage in these discussions as they develop, verify the origin of the genetic material that they use, and ensure that such material was taken in compliance with the domestic law of a provider country.


'/>"/>

Contact: Aaron Lovell
aaron.lovell@wilsoncenter.org
202-691-4320
Woodrow Wilson International Center for Scholars/Science and Technology Innovation Program
Source:Eurekalert

Page: 1

Related biology news :

1. New protocol developed to decontaminate human fetal tissues used for cell transplantation
2. JISC Collections purchases SpringerProtocols
3. NYSCF scientists develop new protocol to ready induced pluripotent stem cell clinical application
4. New protocol recommendations for measuring soil organic carbon sequestration
5. Lower dosage CT-guided lung biopsy protocol maintains quality, minimizes exposure
6. Assessing noise impact of offshore wind farm construction may help protect marine mammals
7. Study maps human impacts on top ocean predators along US west coast
8. How will stem cell therapies impact patient care?
9. Poorly camouflaged insects can kick off a cascade of ecological impacts, new CU-Boulder study finds
10. How tiny organisms make a big impact on clean water
11. New Stroud scientist to advise US Army Corps on environmental impacts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology: